Guardant Health (GH) Non-Current Deffered Revenue (2017 - 2019)

Guardant Health has disclosed Non-Current Deffered Revenue across 3 years of filings, most recently posting $10.6 million for Q3 2019.

• Non-Current Deffered Revenue for Q3 2019 came in at $10.6 million, up 38.58% year-over-year; the trailing twelve-month figure through Sep 2019 was $10.6 million (up 38.58% YoY), and the FY2018 annual result was $7.8 million, up 19.99% from the prior year.
• Non-Current Deffered Revenue came in at $10.6 million for Q3 2019 at Guardant Health, down from $10.9 million in the prior quarter.
• In the past five years, Non-Current Deffered Revenue ranged from a high of $10.9 million in Q2 2019 to a low of $6.5 million in Q4 2017.
• The 3-year median for Non-Current Deffered Revenue is $8.4 million (2018), against an average of $8.7 million.
• Across the five-year window, Non-Current Deffered Revenue rose 19.99% in 2018 and surged 38.58% in 2019, its largest moves.
• Guardant Health's Non-Current Deffered Revenue stood at $6.5 million in 2017, then grew by 19.99% to $7.8 million in 2018, then surged by 34.68% to $10.6 million in 2019.
• The last three Non-Current Deffered Revenue figures came in at $10.6 million (Q3 2019), $10.9 million (Q2 2019), and $9.0 million (Q1 2019), per Business Quant data.